Cargando…

Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: a UK population-based study of diffuse large B-cell lymphoma

AIM: To examine the influence of patient’s age and socio-economic status on treatment and outcome in diffuse large B-cell lymphoma (DLBCL); an aggressive curable cancer, with an incidence rate that increases markedly with age but varies little with socio-economic status. METHODS: Set within a repres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Alexandra, Crouch, Simon, Howell, Debra, Burton, Cathy, Patmore, Russell, Roman, Eve
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676192/ https://www.ncbi.nlm.nih.gov/pubmed/26341588 http://dx.doi.org/10.1016/j.canep.2015.08.015

Ejemplares similares

Emergency admission and survival from aggressive non-Hodgkin lymphoma: A report from the UK's population-based Haematological Malignancy Research Network
por: Kane, Eleanor, et al.
Publicado: (2017)

Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort
por: Wang, Han-I., et al.
Publicado: (2016)

Impact of novel therapies for mantle cell lymphoma in the real world setting: a report from the UK's Haematological Malignancy Research Network (HMRN)
por: Smith, Alexandra, et al.
Publicado: (2018)

Hodgkin lymphoma detection and survival: findings from the Haematological Malignancy Research Network
por: Lamb, Maxine JE, et al.
Publicado: (2019)

A Generic Model for Follicular Lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population–Based Observational Data()
por: Wang, Han-I, et al.
Publicado: (2018)

The impact of rheumatological disorders on lymphomas and myeloma: a report on risk and survival from the UK’s population-based Haematological Malignancy Research Network
por: Kane, Eleanor, et al.
Publicado: (2019)

‘Unpacking’ pathways to lymphoma and myeloma diagnosis: Do experiences align with the Model of Pathways to Treatment? Findings from a UK qualitative study with patients and relatives
por: Howell, Debra, et al.
Publicado: (2020)

Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK's Haematological Malignancy Research Network
por: Smith, A, et al.
Publicado: (2015)

Disease-related factors affecting timely lymphoma diagnosis: a qualitative study exploring patient experiences
por: Howell, Debra A, et al.
Publicado: (2019)

Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort
por: Smith, Alexandra, et al.
Publicado: (2018)

Cohort Profile Update: The Haematological Malignancy Research Network (HMRN) UK population-based cohorts
por: Roman, Eve, et al.
Publicado: (2022)

Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network
por: Howell, Debra A, et al.
Publicado: (2013)

Multiple myeloma: routes to diagnosis, clinical characteristics and survival – findings from a UK population‐based study
por: Howell, Debra, et al.
Publicado: (2017)

Incurable but treatable: Understanding, uncertainty and impact in chronic blood cancers—A qualitative study from the UK’s Haematological Malignancy Research Network
por: Howell, Debra A., et al.
Publicado: (2022)

Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK’s population-based Haematological Malignancy Research Network 2004–15
por: Roman, Eve, et al.
Publicado: (2016)

Treatment decision making (TDM): a qualitative study exploring the perspectives of patients with chronic haematological cancers
por: McCaughan, Dorothy, et al.
Publicado: (2022)

A Patient With Regressed Diffuse Large B-Cell Lymphoma and Aggressive Follicular Lymphoma
por: Sethi, Ashish K, et al.
Publicado: (2021)

The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research
por: Smith, Alexandra, et al.
Publicado: (2010)

Molecular subclusters of follicular lymphoma: a report from the United Kingdom’s Haematological Malignancy Research Network
por: Crouch, Simon, et al.
Publicado: (2022)

Hodgkin's lymphoma and infection: findings from a UK case–control study
por: Newton, R, et al.
Publicado: (2007)

Haematology nurses' perspectives of their patients' places of care and death: A UK qualitative interview study
por: McCaughan, Dorothy, et al.
Publicado: (2019)

Preferred and actual place of death in haematological malignancies: a report from the UK haematological malignancy research network
por: Sheridan, Rebecca, et al.
Publicado: (2021)

The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project
por: Sargent, Daniel J., et al.
Publicado: (2017)

High ETV6 Levels Support Aggressive B Lymphoma Cell Survival and Predict Poor Outcome in Diffuse Large B-Cell Lymphoma Patients
por: Marino, Dario, et al.
Publicado: (2022)

Risk factors and time to symptomatic presentation in leukaemia, lymphoma and myeloma
por: Howell, Debra A, et al.
Publicado: (2015)

Experiences and preferences for psychosocial support: a qualitative study exploring the views of patients with chronic haematological cancers
por: Sheridan, Rebecca, et al.
Publicado: (2023)

Stem cell characteristics promote aggressiveness of diffuse large B-cell lymphoma
por: Chang, Kung-Chao, et al.
Publicado: (2020)

Variations in specialist palliative care referrals: findings from a population-based patient cohort of acute myeloid leukaemia, diffuse large B-cell lymphoma and myeloma
por: Howell, D A, et al.
Publicado: (2015)

Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma: An Underrecognized Aggressive Lymphoma
por: Morgan, Elizabeth A., et al.
Publicado: (2012)

Simultaneous Presence of Follicular Lymphoma, Diffuse Large B-cell Lymphoma, and Hodgkin-like Lymphoma
por: Papoudou-Bai, Alexandra, et al.
Publicado: (2018)

Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort
por: Lamb, Maxine JE, et al.
Publicado: (2021)

Place of death in haematological malignancy: variations by disease sub-type and time from diagnosis to death
por: Howell, Debra A, et al.
Publicado: (2013)

Myeloma: Patient accounts of their pathways to diagnosis
por: Howell, Debra A., et al.
Publicado: (2018)

Site-Specific Survival of Extra Nodal Diffuse Large B-Cell Lymphoma and Comparison With Gastrointestinal Diffuse Large B-Cell Lymphoma
por: Gupta, Varsha, et al.
Publicado: (2022)

Destined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancy
por: Howell, Debra A, et al.
Publicado: (2010)

STAT3 Targets Suggest Mechanisms of Aggressive Tumorigenesis in Diffuse Large B-Cell Lymphoma
por: Hardee, Jennifer, et al.
Publicado: (2013)

Survival and Prognostic Factors in Patients with Aggressive Cutaneous T-cell Lymphomas
por: FRANCESCHI, Joséphine, et al.
Publicado: (2022)

The prognosis of MYC translocation positive diffuse large B‐cell lymphoma depends on the second hit
por: Clipson, Alexandra, et al.
Publicado: (2015)

Determinants of hospital death in haematological cancers: findings from a qualitative study
por: McCaughan, Dorothy, et al.
Publicado: (2018)

Methotrexate-induced Primary Cutaneous Diffuse Large B-cell Lymphoma in Patients with Erythrodermic Cutaneous T-cell Lymphoma
por: DELALEU, Jérémie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d7jtd23rhi22nql00h7loar0g9